0001127602-24-013490.txt : 20240426 0001127602-24-013490.hdr.sgml : 20240426 20240426173357 ACCESSION NUMBER: 0001127602-24-013490 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240425 FILED AS OF DATE: 20240426 DATE AS OF CHANGE: 20240426 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Louie Ngar Yee CENTRAL INDEX KEY: 0001913264 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41455 FILM NUMBER: 24885500 MAIL ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MAIA Biotechnology, Inc. CENTRAL INDEX KEY: 0001878313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-416-8592 MAIL ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-04-25 0001878313 MAIA Biotechnology, Inc. MAIA 0001913264 Louie Ngar Yee 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 1 0 Common Stock 2024-04-25 4 P 0 19665 2.03 A 1167189 D Warrants 2.26 2024-04-25 4 P 0 19665 2.26 A 2024-10-25 2029-10-25 Common Stock 19665 19665 D The common stock was purchased pursuant to a Securities Purchase Agreement dated April 22, 2024 and were issued under the Issuer's 2021 Equity Incentive Plan on April 25, 2024. The warrants were purchased pursuant to a Securities Purchase Agreement dated April 22, 2024 and were deemed options issued under the Issuer's 2021 Equity Inventive Plan on April 25, 2024. The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date. /s/ Louie Ngar Yee 2024-04-26